Atopic Dermatitis Treated Safely with Dupilumab during Pregnancy: A Case Report and Review of the Literature

Dupilumab is currently the only biologic treatment approved for moderate-to-severe atopic dermatitis. Though limited, available clinical data describing dupilumab use in pregnancy have not identified a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. S...

Descripción completa

Detalles Bibliográficos
Autores principales: Lobo, Yolanka, Lee, Ruby C., Spelman, Lynda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Case and Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215998/
https://www.ncbi.nlm.nih.gov/pubmed/34177514
http://dx.doi.org/10.1159/000515246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215998/
https://www.ncbi.nlm.nih.gov/pubmed/34177514
http://dx.doi.org/10.1159/000515246

Ejemplares similares